A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration ... placebo-controlled and active-controlled. " ...

SINGAPORE – Ketamine, the controlled drug ... be declared a “blockbuster drug” with $1 billion in annual sales. Driving its appeal are its rapid effects and non-invasive procedure, said ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat ... Journavx was evaluated in two randomized ...

Ben Strahan thought he’d lost the will to live. It had been a long, isolating year for the Reno-based wildland firefighter.

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

anxiety, insomnia, nausea, dizziness, tingling, or shock-like sensations. Ask your doctor before you stop. They can help you come up with a schedule to help you wean yourself off the drug with ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Erez Aminov, Chairman & Chief Executive Officer of MIRA ...